726 Recurrence Pattern of Endometrial Carcinoma: is There a Correlation with Molecular Classification?
International Journal of Gynecological Cancer(2024)
Academic Division of Gynecology and Obstetric
Abstract
Introduction/Background Despite the good prognosis of early-stage endometrial cancer and the recent advances in terms of risk stratification and treatment, recurrence remains a significant clinical challenge. Aim of this study is to assess the impact of histological and molecular characteristics on recurrence pattern of endometrial cancer. Methodology This study retrospectively evaluated 415 patients with endometrial cancer who underwent primary surgical treatment between 2009 and 2022 at the Academic Division of Gynecology, Mauriziano Hospital, Torino, Italy. Among them, 34 molecularly classified recurrences were observed. All variables were analyzed using Fisher9s exact test for categorical variables and t-test for continuous variables. Univariate and multivariate analysis were performed to assess the relationship between molecular characteristics and pattern of recurrence. Results Abnormal p53 endometrial cancers showed more peritoneal recurrences at univariate and multivariate analysis (p=0.002; OR=18.2; CI: 3.006–111.18). Moreover, peritoneal recurrences in abnormal p53 tumors had shorter recurrence-free survival than in the wild-type p53 group (median 12.66 vs. 21.65 months, Logrank, p<0.001). A trend toward a higher prevalence of positive peritoneal cytology at onset (p=0.085) and high-grade disease (p=0.092) was observed in tumors with diffuse peritoneal recurrence. However, no correlations were detected in other recurrence sites (lung, liver, bone and lymph nodes) for the examined variables. Conclusion This investigation revealed a correlation between molecular classification and pattern of recurrence in endometrial cancer patients. p53abn patients experienced abdominal relapse more often and earlier than wild-type ones. Future prospective studies are needed to confirm these assumptions in order to enable clinicians to build an increasingly tailored follow-up pathway. Disclosures The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. No specific funding was obtained for this study.
MoreTranslated text
Key words
Endometrial Carcinoma
求助PDF
上传PDF
View via Publisher
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
- Pretraining has recently greatly promoted the development of natural language processing (NLP)
- We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
- We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
- The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
- Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper